Novartis AG (ADR) (NVS)

  • NYSE: NVS
  • Mkt.Cap.:122.95B
Focused: Healthcare > Biopharmaceuticals (^BPHRM)

Classification

Sector
Healthcare
Biopharmaceuticals
- Focused
- Sector Pure-Play

Sector companies

Top 5 competitive companies in Biopharmaceuticals (^BPHRM) :

Ticker Name Mkt.Cap.
PFE Pfizer Inc. 134.80B
RHHBY Roche Holding Ltd. (ADR) 122.07B
MRK Merck & Co., Inc. 110.90B
GSK GlaxoSmithKline plc (ADR) 102.56B
SNY Sanofi-Aventis SA (ADR) 80.16B

Relationships

Sample 8 relationships grouped by relationhip type.

Ticker Name
Competitors
Defined by Others ATRM Aetrium, Inc.
Defined by Others AKRX Akorn, Inc.
Customers
Defined by the Company MRK Merck & Co., Inc.
Defined by the Company BAYRY Bayer AG (ADR)
Suppliers
Defined by the Company ELN Elan Corporation, plc (ADR)
Defined by the Company HGSI Human Genome Sciences
Partners
Defined by the Company ELN Elan Corporation, plc (ADR)
Defined by the Company HGSI Human Genome Sciences
- Defined by the Company
- Defined by Others

Products & Services

Sample products & services from Biopharmaceuticals (^BPHRM) :

  • 4-Way Fast Acting Nasal Spray (Phenylephrine Hydrochloride)
  • A(H1N1) Influenza Vaccine
  • ABJ879 (Microtubule Stabilizer)

Relative Performance (1Y)

Relative Chart
  • - Novartis AG (ADR) (NVS)
  • - S&P 500 INDEX (SPX)
  • - Healthcare > Biopharmaceuticals (^BPHRM)

Subscribe to an RSS Feed Research Reports

more »